Divalproex CF. Propanolol for Migraine Prophylaxis

Divalproex CF. Propanolol for Migraine Prophylaxis

Migraine frequency was reduced in two-thirds of adult patients treated at the Allegheny Hdche Ctr, Pittsburgh, with either divalproex or propanolol cf to 19% with placebo.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 1997-11-01
Series:Pediatric Neurology Briefs
Subjects:
migraine
divalproex
propanolol
Online Access:https://www.pediatricneurologybriefs.com/articles/2291
id doaj-f457834975fa4952a3c8725b089d5779
record_format Article
spelling doaj-f457834975fa4952a3c8725b089d57792020-11-25T02:15:42ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64821997-11-011111888810.15844/pedneurbriefs-11-11-122278Divalproex CF. Propanolol for Migraine ProphylaxisJ Gordon Millichap0Northwestern University Feinberg School of MedicineMigraine frequency was reduced in two-thirds of adult patients treated at the Allegheny Hdche Ctr, Pittsburgh, with either divalproex or propanolol cf to 19% with placebo.https://www.pediatricneurologybriefs.com/articles/2291migrainedivalproexpropanolol
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Divalproex CF. Propanolol for Migraine Prophylaxis
Pediatric Neurology Briefs
migraine
divalproex
propanolol
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Divalproex CF. Propanolol for Migraine Prophylaxis
title_short Divalproex CF. Propanolol for Migraine Prophylaxis
title_full Divalproex CF. Propanolol for Migraine Prophylaxis
title_fullStr Divalproex CF. Propanolol for Migraine Prophylaxis
title_full_unstemmed Divalproex CF. Propanolol for Migraine Prophylaxis
title_sort divalproex cf. propanolol for migraine prophylaxis
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 1997-11-01
description Migraine frequency was reduced in two-thirds of adult patients treated at the Allegheny Hdche Ctr, Pittsburgh, with either divalproex or propanolol cf to 19% with placebo.
topic migraine
divalproex
propanolol
url https://www.pediatricneurologybriefs.com/articles/2291
work_keys_str_mv AT jgordonmillichap divalproexcfpropanololformigraineprophylaxis
_version_ 1724894414823751680

Similar Items